Diabetes org apologizes for ejecting scientists over criticism of Trump
The American Diabetes Association faced a significant institutional crisis on Friday when security personnel forcibly removed five prominent diabetes researchers from the organization's annual conference after they attempted to distribute scientific literature critical of Trump administration policies affecting biomedical research. The incident involved Steven Kahn, professor of medicine at the University of Washington and editor-in-chief of the ADA's flagship journal Diabetes Care, alongside former ADA President Desmond Schatz of the University of Florida and three additional leading diabetes scientists. The researchers were distributing copies of an April editorial published in Diabetes Care itself—the association's official peer-reviewed journal—when they were ejected from the conference's opening session. The confrontation occurred at a particularly sensitive moment, as the conference was meant to feature remarks from Jay Bhattacharya, director of the National Institutes of Health under the Trump administration, though Bhattacharya ultimately withdrew from the engagement at the last minute, with senior NIH official Rick Woychik delivering remarks instead. The ADA's leadership subsequently issued a public apology acknowledging the impropriety of the removal, signaling recognition that the organization had overstepped in restricting the scientists' distribution of peer-reviewed criticism.
This episode reflects a deeper institutional tension within the scientific community regarding the relationship between professional organizations and political pressures. The American Diabetes Association, like many established research institutions, maintains complex relationships with government funding bodies, pharmaceutical companies, and political figures whose policies directly influence research trajectories and resource allocation. The removal of five credentialed scientists for distributing their own peer-reviewed editorial published through official organizational channels represents a troubling precedent for scientific discourse and institutional independence. Historically, professional scientific associations have positioned themselves as stewards of knowledge production independent from political influence, yet the incident demonstrates how even ostensibly neutral organizations can face pressure—whether explicit or self-imposed—to restrict critical scientific commentary. The timing of this controversy intersects with broader debates about biomedical research funding, regulatory environments, and the appropriate boundaries between scientific institutions and political actors. Understanding this incident requires recognizing that scientific organizations operate within complex incentive structures where government funding relationships, donor expectations, and reputational concerns can create tension with the fundamental scientific principle of open peer review and critical discourse.
The specific details of this confrontation illuminate important dimensions of institutional governance and scientific communication. The researchers were distributing copies of an editorial published in Diabetes Care, establishing that the material being shared represented officially vetted scientific commentary rather than unauthorized or fringe criticism. Steven Kahn's dual role as both a principal target of the removal and the editor-in-chief of the very journal that published the editorial creates a particularly significant tension—the highest editorial authority of the organization's official publication was physically removed from the conference for sharing the editorial that he himself edited and approved for publication. The substitution of Rick Woychik for Jay Bhattacharya in the opening remarks suggests additional complexity in the administration's engagement with scientific organizations, potentially indicating sensitivity around direct interaction with institutions expressing institutional-level criticism. The ADA's subsequent public apology from organizational leadership constitutes explicit acknowledgment that the removal violated appropriate professional norms, offering tacit admission that institutional interests may have initially motivated the decision to eject the scientists.
For technology and biomedical research professionals, this incident carries concrete implications for the environment surrounding federally-funded scientific research and academic freedom. The National Institutes of Health represents the primary funding mechanism for basic and translational biomedical research across American universities and research institutions, controlling annual appropriations exceeding thirty billion dollars. When professional scientific organizations face pressure—whether real or perceived—to restrict criticism of government research policies, the downstream consequences extend throughout the entire research enterprise affecting grant award mechanisms, publication standards, and researcher career trajectories. Scientists at universities and research hospitals considering whether to voice concerns about research policy face a potentially chilling precedent when professional conferences restrict distribution of peer-reviewed criticism. Additionally, the incident demonstrates how institutional partnerships with government agencies and high-ranking officials can create conflict between organizational financial interests and commitments to scientific independence. For individual researchers, the removal incident raises practical questions about the safety and appropriateness of scientific discourse at major professional meetings where government officials participate, potentially affecting researcher willingness to present findings or commentary that challenges current policy frameworks.
The broader significance of this episode extends beyond diabetes research to fundamental questions about scientific institution governance during periods of political tension. The American Diabetes Association's position within the biomedical research ecosystem means that its decisions regarding scientific discourse influence norms across allied professional organizations in immunology, cardiology, oncology, and other research domains. Scientific organizations face recurring decisions about balancing access to government relationships and funding with institutional commitments to scientific freedom and critical inquiry. When major organizations prioritize government engagement and donor satisfaction over researcher protections, informal institutional pressure toward self-censorship increases. The incident also reflects a particular vulnerability of medical research organizations serving both scientific and public health advocacy functions—the ADA manages research advancement while also serving patient advocacy roles requiring political engagement, creating inherent tensions absent from purely research-focused academic societies. Historical patterns suggest that periods of contentious government-science relationships often produce significant professional organization reforms regarding governance transparency, editorial independence, and researcher protections. The incident signals broader strain within the American scientific establishment between political pragmatism and principle, with professional organizations emerging as critical pressure points where these tensions manifest publicly.
Moving forward, multiple developments warrant monitoring by observers of scientific governance and research policy. The ADA's internal deliberations regarding governance reforms and safeguards for scientific expression at future conferences will establish whether the organization's apology represents genuine institutional recalibration or merely crisis management. Additionally, the response of other major biomedical research organizations—including the American Association for Cancer Research, the American Heart Association, and the Federation of American Societies for Experimental Biology—will indicate whether the incident influences norms across the professional research ecosystem regarding government engagement and scientific communication restrictions. Specific attention should focus on how these organizations address researcher protections and editorial independence in their governance documents during 2025 and beyond. The intersection between scientific research funding mechanisms and political environments will likely produce additional flashpoints, making the institutional precedents established in this moment particularly consequential. Research community observers should track whether professional scientific societies implement explicit policies protecting researcher rights to distribute peer-reviewed scholarship and criticism at conferences, and whether such commitments establish enforceable standards across their member institutions and conferences.
